Verve Therapeutics, Inc. announced it raised $94 Million in an initial filing from an offering of $94 Million
Verve Therapeutics, Inc. announced it raised $94 Million in an initial filing from an offering of $94 Million
01/22/21, 8:59 PM
Location
Money raised
$94 million
Industry
health care
biotechnology
Company Info
Location
500 technology square
boston, massachusetts, united states
Additional Info
Verve was purpose-built to disrupt today’s chronic care model for CVD, with a team of experts in cardiovascular medicine, genetics, gene editing, delivery technologies and drug development. heart-1 is currently enrolling patients with heterozygous familial hypercholesterolemia (HeFH) in the United Kingdom and New Zealand.